Ada Health has quietly built one of the most accurate AI symptom assessment tools available. Founded in Berlin in 2011, the company spent years developing a medical knowledge base and reasoning engine before launching its consumer app. Users describe their symptoms through a conversational interface, and Ada provides possible conditions ranked by likelihood.
The app has been downloaded over 13 million times and has completed more than 30 million symptom assessments. What makes Ada different from basic symptom checkers is the depth of its medical reasoning. The AI considers rare conditions, asks follow-up questions based on previous answers, and adapts to individual patient profiles. Multiple clinical studies have shown Ada’s accuracy outperforms comparable tools.
Beyond the consumer app, Ada works with health systems and pharmaceutical companies through its enterprise platform. Hospitals can integrate Ada’s assessment engine into their own patient intake workflows, helping triage patients more efficiently. The company has raised over $200 million and operates globally, with its medical content available in multiple languages. Ada sits at the intersection of AI and clinical decision support, and it’s one of the few companies in this space with serious clinical validation behind its technology.
